Crescent Capital BDC (CCAP) to Release Earnings on Wednesday

Crescent Capital BDC (NASDAQ:CCAP) is projected to release its earnings data after the market closes on Wednesday, February 19th. Analysts expect Crescent Capital BDC to post earnings of $0.56 per share and revenue of $47.27 million for the quarter. Persons interested in participating in the company’s earnings conference call can do so using this link.

Crescent Capital BDC (NASDAQ:CCAP) last announced its quarterly earnings data on Tuesday, November 12th. The company reported $0.64 EPS for the quarter, topping analysts’ consensus estimates of $0.57 by $0.07. The business had revenue of $51.63 million for the quarter, compared to analyst estimates of $48.76 million. Crescent Capital BDC had a net margin of 47.06% and a return on equity of 12.20%. During the same quarter in the previous year, the firm posted $0.59 earnings per share. On average, analysts expect Crescent Capital BDC to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Crescent Capital BDC Stock Performance

Shares of CCAP stock opened at $19.67 on Wednesday. The company’s fifty day simple moving average is $19.43 and its 200-day simple moving average is $18.80. The company has a quick ratio of 1.26, a current ratio of 1.26 and a debt-to-equity ratio of 1.14. The firm has a market cap of $728.97 million, a PE ratio of 7.71 and a beta of 0.81. Crescent Capital BDC has a 12 month low of $16.02 and a 12 month high of $20.03.

Crescent Capital BDC Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, January 15th. Stockholders of record on Tuesday, December 31st were given a $0.42 dividend. This represents a $1.68 dividend on an annualized basis and a dividend yield of 8.54%. The ex-dividend date of this dividend was Tuesday, December 31st. This is a positive change from Crescent Capital BDC’s previous quarterly dividend of $0.07. Crescent Capital BDC’s payout ratio is currently 65.88%.

Analysts Set New Price Targets

Several analysts have issued reports on CCAP shares. Wells Fargo & Company upped their price target on shares of Crescent Capital BDC from $18.00 to $19.00 and gave the stock an “equal weight” rating in a research report on Wednesday, January 29th. Keefe, Bruyette & Woods upped their price target on shares of Crescent Capital BDC from $19.00 to $20.00 and gave the stock an “outperform” rating in a research report on Monday, November 25th. One investment analyst has rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $19.33.

Crescent Capital BDC Company Profile

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.